Effect of Tourniquet on Local Tissue Concentrations of Cefazolin During Total Knee Arthroplasty: A Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Tourniquet inflation during total knee arthroplasty (TKA) is commonly used to reduce bleeding in the surgical field; thereby facilitating exposure and cementation. However, reducing circulation to the leg may also reduce antibiotic distribution to the peri-incisional tissues. Once inflated, further parenteral addition of antibiotics is not likely to achieve peak concentration. Some studies propose techniques of regional prophylaxis with a tourniquet to achieve higher cefazolin tissue concentrations. To our knowledge, the effect of tourniquet application on antibiotic tissue concentrations during total knee arthroplasty has not been explored. Furthermore, the effect of time from dose to incision, participants weight, and length of surgery on local tissue concentrations of Ancef are poorly understood. Considering that infections remain the leading source of early reoperation and revision surgery, insight and optimization of local tissue antibiotics is of paramount interest.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: t
View:

• Adults ages 18-85 who require a primary total knee replacement

• Any gender

• Osteoarthritis, rheumatoid arthritis, avascular necrosis

Locations
Other Locations
Canada
Dr, Adam Hart
RECRUITING
Montreal
Contact Information
Primary
Adam Hart, MD
adam.hart@mgcill.ca
514-934-1934
Backup
Karen Smith, CRA
karen.smith@muhc.mcgill.ca
514-934-1934
Time Frame
Start Date: 2021-09-16
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 50
Treatments
Active_comparator: Tourniquet
25 participants with tourniquet application
No_intervention: No tourniquet
25 participants without tourniquet application
Related Therapeutic Areas
Sponsors
Leads: McGill University Health Centre/Research Institute of the McGill University Health Centre

This content was sourced from clinicaltrials.gov